化学性质
| Storage | Store at -20°C |
| M.Wt | 560.59 |
| Formula | C30H30F2N6O3 |
| Solubility | insoluble in H2O; ≥27.4 mg/mL in EtOH; ≥42.3 mg/mL in DMSO |
| Chemical Name | 4-((S)-4-acryloyl-2-methylpiperazin-1-yl)-6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-(2-isopropyl-4-methylpyridin-3-yl)pyrido[2,3-d]pyrimidin-2(1H)-one |
| Canonical SMILES | O=C(N1CCN([C@@H](C)C1)C2=NC(N(C3=C2C=C(C(C4=C(O)C=CC=C4F)=N3)F)C5=C(C=CN=C5C(C)C)C)=O)C=C |
| 运输条件 | 蓝冰运输或根据您的需求运输。 |
| 一般建议 | 为了使其更好的溶解，请用37℃加热试管并在超声波水浴中震动片刻。不同厂家不同批次产品溶解度各有差异，仅做参考。若实验所需浓度过大至产品溶解极限，请添加助溶剂助溶或自行调整浓度。溶液形式一般不宜长期储存，请尽快用完。 |
资料参考
AMG-510 is an effective, orally bioavailable, selective KRAS G12C covalent inhibitor. AMG-510 locks KRAS G12C in an inactive GDP constraint. AMG-510 is the first KRAS G12C inhibitor to be clinically developed, which can cause KRAS G12C tumor regression.
